Skip to content

Mirum Pharmaceuticals

US · MIRM #2051 by market cap Listed 2019
96.13 +0.62 +0.65%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Founded
2018
CEO
Mr. Christopher Peetz
Employees
372
Headquarters
Foster City, California, United States of America
Fiscal year end
12-31
Website
mirumpharma.com

Company profile

Exchange
US
Symbol
MIRM
Market-cap rank
#2051
Listing date
2019-07-18
Market cap
6.28B
Float cap
5.45B
Shares out
65.28M
Float shares
56.74M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Mirum Pharmaceuticals discussion 0 comments

Add a comment